Vaccines for Africa Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Anzio Road Observatory, Cape Town 7925, South Africa.
BMC Med. 2013 Mar 14;11:66. doi: 10.1186/1741-7015-11-66.
The implementation of strategic immunization plans whose development is informed by available locally-relevant research evidence should improve immunization coverage and prevent disease, disability and death in Africa. In general, health research helps to answer questions, generate the evidence required to guide policy and identify new tools. However, factors that influence the publication of immunization research in Africa are not known. We, therefore, undertook this study to fill this research gap by providing insights into factors associated with childhood immunization research productivity on the continent. We postulated that research productivity influences immunization coverage.
We conducted a bibliometric analysis of childhood immunization research output from Africa, using research articles indexed in PubMed as a surrogate for total research productivity. We used zero-truncated negative binomial regression models to explore the factors associated with research productivity.
We identified 1,641 articles on childhood immunization indexed in PubMed between 1974 and 2010 with authors from Africa, which represent only 8.9% of the global output. Five countries (South Africa, Nigeria, The Gambia, Egypt and Kenya) contributed 48% of the articles. After controlling for population and gross domestic product, The Gambia, Guinea-Bissau and Sao Tome and Principe were the most productive countries. In univariable analyses, the country's gross domestic product, total health expenditure, private health expenditure, and research and development expenditure had a significant positive association with increased research productivity. Immunization coverage, adult literacy rate, human development index and physician density had no significant association. In the multivarable model, only private health expenditure maintained significant statistical association with the number of immunization articles.
Immunization research productivity in Africa is highly skewed, with private health expenditure having a significant positive association. However, the current contribution of authors from Africa to global childhood immunization research output is minimal. The lack of association between research productivity and immunization coverage may be an indication of lack of interactive communication between health decision-makers, program managers and researchers; to ensure that immunization policies and plans are always informed by the best available evidence.
实施以现有本地相关研究证据为指导的战略性免疫规划,应能提高免疫接种率,预防非洲的疾病、残疾和死亡。一般来说,卫生研究有助于回答问题、生成指导政策所需的证据并确定新工具。然而,影响非洲免疫接种研究发表的因素尚不清楚。因此,我们开展了这项研究,以通过深入了解影响非洲儿童免疫接种研究成果的因素来填补这一研究空白。我们假设研究成果会影响免疫接种率。
我们对非洲儿童免疫接种研究成果进行了文献计量分析,使用在 PubMed 中索引的研究文章作为总研究成果的替代指标。我们使用零截断负二项回归模型来探讨与研究成果相关的因素。
我们在 PubMed 中确定了 1974 年至 2010 年期间索引的 1641 篇关于儿童免疫接种的文章,这些文章的作者来自非洲,仅占全球产出的 8.9%。五个国家(南非、尼日利亚、冈比亚、埃及和肯尼亚)贡献了 48%的文章。在控制人口和国内生产总值后,冈比亚、几内亚比绍和圣多美和普林西比是最具生产力的国家。在单变量分析中,国家的国内生产总值、总卫生支出、私人卫生支出和研发支出与研究成果的增加呈显著正相关。免疫覆盖率、成人识字率、人类发展指数和医生密度与研究成果无显著相关性。在多变量模型中,只有私人卫生支出与免疫文章数量保持显著的统计学关联。
非洲的免疫接种研究成果高度偏向,私人卫生支出与研究成果呈显著正相关。然而,目前非洲作者对全球儿童免疫接种研究成果的贡献微不足道。研究成果与免疫覆盖率之间缺乏关联可能表明卫生决策者、项目管理人员和研究人员之间缺乏互动交流;以确保免疫政策和计划始终以最佳现有证据为依据。